MAGNEVIST Drug Patent Profile
✉ Email this page to a colleague
When do Magnevist patents expire, and what generic alternatives are available?
Magnevist is a drug marketed by Bayer Hlthcare and is included in two NDAs.
The generic ingredient in MAGNEVIST is gadopentetate dimeglumine. There is one drug master file entry for this compound. Additional details are available on the gadopentetate dimeglumine profile page.
Summary for MAGNEVIST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 30 |
Patent Applications: | 1,327 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MAGNEVIST |
What excipients (inactive ingredients) are in MAGNEVIST? | MAGNEVIST excipients list |
DailyMed Link: | MAGNEVIST at DailyMed |
Recent Clinical Trials for MAGNEVIST
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dipan Shah | N/A |
Guerbet | N/A |
Patricia Kim Phuong Nguyen | Phase 4 |
US Patents and Regulatory Information for MAGNEVIST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | MAGNEVIST | gadopentetate dimeglumine | INJECTABLE;INJECTION | 019596-001 | Jun 2, 1988 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Hlthcare | MAGNEVIST | gadopentetate dimeglumine | INJECTABLE;INJECTION | 021037-001 | Mar 10, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MAGNEVIST
International Patents for MAGNEVIST
See the table below for patents covering MAGNEVIST around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 512863 | Diagnostisk komposition innehållande minst ett fysiologiskt fördragbart komplexsalt | ⤷ Try a Trial |
Denmark | 89794 | ⤷ Try a Trial | |
Netherlands | 9900020 | ⤷ Try a Trial | |
Denmark | 170460 | ⤷ Try a Trial | |
Sweden | 510582 | Diagnostiska medel innehållande minst ett fysiologiskt fördragbart komplexsalt av anjonen av en komplexbildande syra | ⤷ Try a Trial |
Netherlands | 195071 | ⤷ Try a Trial | |
United Kingdom | 8529903 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MAGNEVIST
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0071564 | SPC/GB93/060 | United Kingdom | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |